ATE414540T1 - Impfstoffe gegen allergien - Google Patents

Impfstoffe gegen allergien

Info

Publication number
ATE414540T1
ATE414540T1 AT03740967T AT03740967T ATE414540T1 AT E414540 T1 ATE414540 T1 AT E414540T1 AT 03740967 T AT03740967 T AT 03740967T AT 03740967 T AT03740967 T AT 03740967T AT E414540 T1 ATE414540 T1 AT E414540T1
Authority
AT
Austria
Prior art keywords
vaccines against
against allergies
polypeptides
allergies
adjuvants
Prior art date
Application number
AT03740967T
Other languages
English (en)
Inventor
Lars Hellman
Stephen Persson
Asa Jansson
Original Assignee
Resistentia Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resistentia Pharmaceuticals Ab filed Critical Resistentia Pharmaceuticals Ab
Application granted granted Critical
Publication of ATE414540T1 publication Critical patent/ATE414540T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT03740967T 2002-09-05 2003-06-02 Impfstoffe gegen allergien ATE414540T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40864802P 2002-09-05 2002-09-05

Publications (1)

Publication Number Publication Date
ATE414540T1 true ATE414540T1 (de) 2008-12-15

Family

ID=31978650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740967T ATE414540T1 (de) 2002-09-05 2003-06-02 Impfstoffe gegen allergien

Country Status (9)

Country Link
US (2) US20040054146A1 (de)
EP (1) EP1545607B1 (de)
JP (1) JP2006510588A (de)
AT (1) ATE414540T1 (de)
AU (1) AU2003297953B2 (de)
CA (1) CA2497660A1 (de)
DE (1) DE60324816D1 (de)
ES (1) ES2316780T3 (de)
WO (1) WO2004022094A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc ｅＭＩＰを有効成分とする水溶性製剤
GB2500204A (en) * 2012-03-13 2013-09-18 Intercell Ag Vaccine comprising aluminium adjuvant having low levels of contaminating heavy metal ions
US9895437B2 (en) 2012-04-18 2018-02-20 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines
ES3063128T3 (en) * 2018-03-20 2026-04-15 Sanofi Pasteur Ltd Methods for determining adjuvanted protein concentration and percent adsorption using intrinsic fluorescence and system implemented to perform the method
KR20230110249A (ko) * 2020-09-17 2023-07-21 니오베크스 IgE-매개 염증성 장애를 치료하기 위한 IgE 단편을 포함하는 면역원성 생성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
AU630591B2 (en) * 1987-07-06 1992-11-05 Peptide Technology Limited Growth hormone related peptide
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EP2361635A3 (de) * 2000-08-30 2011-09-14 Pfizer Products Inc. Anti-IgE Vakzine
WO2003096966A2 (en) * 2002-05-21 2003-11-27 Resistentia Pharmaceuticals Ab Chimeric ige polypeptides and host cells

Also Published As

Publication number Publication date
US20040054146A1 (en) 2004-03-18
US20090191268A1 (en) 2009-07-30
DE60324816D1 (de) 2009-01-02
WO2004022094A1 (en) 2004-03-18
AU2003297953A1 (en) 2004-03-29
CA2497660A1 (en) 2004-03-18
EP1545607B1 (de) 2008-11-19
ES2316780T3 (es) 2009-04-16
JP2006510588A (ja) 2006-03-30
EP1545607A1 (de) 2005-06-29
AU2003297953B2 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
TW200732349A (en) Anti-OX40L antibodies and methods using same
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
TW200745161A (en) Stable antibody formulation
PT2298287T (pt) Composições estabilizadas de polipéptidos de fator vii
CY1112862T1 (el) Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα
DK1501815T3 (da) Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer
CY1117124T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
NO20055018D0 (no) Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
IL214325A (en) Antibody against cmet, a drug that includes and uses it
PL1971366T3 (pl) Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposoby i zastosowanie
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
NO20044898L (no) Nye etonogestrel estere
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
DK1596870T4 (da) Højdosis-ibandronatformulering
SE0301650D0 (sv) Novel compounds
DE60324816D1 (de) Impfstoffe gegen allergien
DE60331541D1 (de) Gaserzeugende Zusammensetzung
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
IL173929A0 (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
DE60207833D1 (de) Peptiddeformylase-hemmer
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
NO20044186L (no) Peptid-deformylaseinhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties